Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Denali Therapeutics (DNLI) Receivables - Other (2017 - 2022)

Denali Therapeutics has reported Receivables - Other over the past 5 years, most recently at $357000.0 for Q2 2022.

  • Quarterly Receivables - Other fell 77.22% to $357000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $357000.0 through Jun 2022, down 77.22% year-over-year, with the annual reading at $1.2 million for FY2021, 78.39% down from the prior year.
  • Receivables - Other was $357000.0 for Q2 2022 at Denali Therapeutics, down from $1.2 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $5.7 million in Q4 2020 and troughed at $357000.0 in Q2 2022.
  • The 4-year median for Receivables - Other is $1.2 million (2021), against an average of $2.0 million.
  • Year-over-year, Receivables - Other skyrocketed 154.74% in 2018 and then crashed 78.39% in 2021.
  • A 4-year view of Receivables - Other shows it stood at $1.2 million in 2018, then skyrocketed by 380.03% to $5.7 million in 2020, then crashed by 78.39% to $1.2 million in 2021, then crashed by 70.88% to $357000.0 in 2022.
  • Per Business Quant, the three most recent readings for DNLI's Receivables - Other are $357000.0 (Q2 2022), $1.2 million (Q4 2021), and $1.2 million (Q3 2021).